Needham & Company LLC Boosts CVS Health (CVS) Price Target to $85.00


It has outperformed by 12.98% the S&P500.

CVS Health Corporation (CVS)'s average Piotroski F-Score: 6 during the last 7 years. Pggm Invests reported 0.45% in CVS Health Corporation (NYSE:CVS). Chicago Partners Investment Group LLC now owns 10,667 shares of the pharmacy operator's stock worth $867,000 after acquiring an additional 7,169 shares in the last quarter. CVS Health Corp has a one year low of $69.30 and a one year high of $98.67. Corporate insiders own 0.58% of the company's stock. The shares were sold at an average price of $83.07, for a total value of $20,032,330.50. It has underperformed by 41.10% the S&P500. The institutional investor held 494,283 shares of the medical and nursing services company at the end of 2017Q2, valued at $39.77M, down from 598,056 at the end of the previous reported quarter.

Investors sentiment decreased to 0.92 in 2017 Q2. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.55 and a current ratio of 1.05. It dived, as 84 investors sold CVS shares while 559 reduced holdings. Several hedge funds have recently made changes to their positions in CVS. The overall volume in the last trading session was 2.75 million shares. Peak6 Invests Ltd Partnership reported 98,539 shares. Jupiter Asset Mngmt accumulated 0.46% or 163,697 shares. 870,302 are held by St James Inv Limited Liability Com. Autus Asset Mngmt Ltd Limited Liability Company reported 0.15% stake. Following the sale, the executive vice president now directly owns 43,178 shares of the company's stock, valued at approximately $3,504,758.26. Westport Asset Mngmt, a Connecticut-based fund reported 27,792 shares. Uss Investment Ltd reported 321,700 shares. Welch Cap Limited Liability holds 2.02% of its portfolio in CVS Health Corporation (NYSE:CVS) for 75,669 shares. Commercial Bank Of Stockton owns 31,831 shares. Oak Associates Ltd Oh, a Ohio-based fund reported 204,771 shares. Coastline Tru Company owns 36,499 shares.

More notable recent CVS Health Corporation (NYSE:CVS) news were published by: which released: "CVS Health - Attractive Long-Term Income Play" on November 24, 2017, also with their article: "Exclusive: CVS eyes major expansion of health clinics with Aetna deal - sources" published on December 01, 2017, published: "CVS Health: Solid - A Portfolio Analysis" on November 27, 2017. Therefore 68% are positive. Mizuho has "Buy" rating and $108 target. Also, EVP Thomas M. Moriarty sold 20,547 shares of the firm's stock in a transaction that occurred on Monday, October 2nd. The firm now has a hold rating on the pharmacy operator's stock. Citigroup maintained CVS Health Corporation (NYSE:CVS) rating on Monday, November 13.

The stock now shows its YTD (Year to Date) performance of -9.54 percent, whereas its Weekly performance stands at -2.75%. CVS Health Corp had a return on equity of 17.55% and a net margin of 3.00%.

CVS Health (NYSE:CVS) last posted its quarterly earnings data on Monday, November 6th. Morgan Stanley has "Equal-Weight" rating and $104 target. The company's revenue was up 3.5% compared to the same quarter last year. equities research analysts anticipate that CVS Health will post 5.9 earnings per share for the current year. They expect $0.66 EPS, 0.00% or $0.00 from last year's $0.66 per share.

CVS Health Corporation (NYSE:CVS) has an ERP5 rank of 833.

Since June 12, 2017, it had 0 buys, and 1 sale for $18.44 million activity.

CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The pharmacy operator reported $1.50 EPS for the quarter, beating the consensus estimate of $1.49 by $0.01. MMM's profit will be $1.19B for 30.03 P/E if the $2.00 EPS becomes a reality. After $1.50 actual earnings per share reported by CVS Health Corporation for the previous quarter, Wall Street now forecasts 26.67 % EPS growth. Segment Wealth Management holds 17,179 shares or 0.08% of its portfolio. Metropolitan Life Insurance Ny holds 2.98 million shares. Universal Hlth Svcs Inc (NYSE:UHS) was raised too.

When looking at the investment recommendation on say a scale of 1 to 5 (1 being a strong buy, 3 a hold, and 5 a sell), CVS is given a 2.20 while 2.90 placed for M. This means that analysts are more bullish on the outlook for M stocks. 3M had 65 analyst reports since July 24, 2015 according to SRatingsIntel. On Monday, August 14 the stock rating was downgraded by Wolfe Research to "Peer Perform". The rating was maintained by RBC Capital Markets with "Hold" on Wednesday, July 26. Mizuho maintained the shares of CVS in report on Thursday, June 23 with "Buy" rating. Robert W. Baird maintained CVS Health Corporation (NYSE:CVS) on Friday, October 27 with "Hold" rating. As per Monday, October 12, the company rating was maintained by Susquehanna. On Wednesday, April 27 the stock rating was maintained by Deutsche Bank with "Buy". The rating was maintained by Oppenheimer on Monday, November 2 with "Outperform". The company was maintained on Friday, July 22 by FBR Capital.

Investors sentiment increased to 1.15 in 2017 Q2. Its up 0.10, from 0.81 in 2017Q1. 131 funds opened positions while 449 raised stakes. Bancorp Of The West reported 85,739 shares or 0.89% of all its holdings. A ratio over 1 indicates that the market is willing to pay more for the shares. Farmers Bank & Trust reported 1,950 shares. Twitter, Inc. (NYSE:TWTR) has risen 29.68% since December 7, 2016 and is uptrending. Vetr downgraded shares of CVS Health Corp from a "buy" rating to a "hold" rating and set a $85.78 price objective for the a report on Thursday, April 27th. 165,734 are owned by Gw Henssler. AXA grew its stake in shares of CVS Health by 14.8% during the 3rd quarter. 67,494 are held by S&Co. Barry Advsr Ltd Co has 5,054 shares for 0.15% of their portfolio. Hamilton Point Investment Advsr Lc accumulated 1.7% or 25,669 shares.